Jinhe Biotechnology (002688.SZ) released its semi-annual performance, with a net profit attributable to the parent company of 1.38 billion yuan, an increase of 51.52%.

Wise Finance App News, Jinhe Biotechnology (002688.SZ) released its 2025 half-year report, with the company's operating income reaching 1.39 billion yuan, a year-on-year increase of 30.45%. Net profit attributable to shareholders of the listed company was 138 million yuan, a year-on-year increase of 51.52%. Net profit attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 128 million yuan, a year-on-year increase of 50.88%. Basic earnings per share were 0.1787 yuan.